BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 30955386)

  • 1. Deep eutectic solvents comprising active pharmaceutical ingredients in the development of drug delivery systems.
    Pedro SN; Freire MG; Freire CSR; Silvestre AJD
    Expert Opin Drug Deliv; 2019 May; 16(5):497-506. PubMed ID: 30955386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES).
    Kalantri S; Vora A
    Drug Dev Ind Pharm; 2024 May; 50(5):387-400. PubMed ID: 38634708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies.
    Duarte AR; Ferreira AS; Barreiros S; Cabrita E; Reis RL; Paiva A
    Eur J Pharm Biopharm; 2017 May; 114():296-304. PubMed ID: 28189620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailor-made solvents for pharmaceutical use? Experimental and computational approach for determining solubility in deep eutectic solvents (DES).
    Palmelund H; Andersson MP; Asgreen CJ; Boyd BJ; Rantanen J; Löbmann K
    Int J Pharm X; 2019 Dec; 1():100034. PubMed ID: 31993583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Ionic Liquids in the Pharmaceutical Field: An Overview of Relevant Applications.
    Pedro SN; R Freire CS; Silvestre AJD; Freire MG
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic deep eutectic solvents: A comprehensive review of their thermodynamics, microstructure and drug delivery applications.
    Abdelquader MM; Li S; Andrews GP; Jones DS
    Eur J Pharm Biopharm; 2023 May; 186():85-104. PubMed ID: 36907368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview and thermodynamic modelling of deep eutectic solvents as co-solvents to enhance drug solubilities in water.
    Zarei A; Haghbakhsh R; Raeissi S
    Eur J Pharm Biopharm; 2023 Dec; 193():1-15. PubMed ID: 37838144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionic liquids in drug delivery.
    Shamshina JL; Barber PS; Rogers RD
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1367-81. PubMed ID: 23795613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems.
    Aroso IM; Silva JC; Mano F; Ferreira AS; Dionísio M; Sá-Nogueira I; Barreiros S; Reis RL; Paiva A; Duarte AR
    Eur J Pharm Biopharm; 2016 Jan; 98():57-66. PubMed ID: 26586342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging frontiers of deep eutectic solvents in drug discovery and drug delivery systems.
    Zainal-Abidin MH; Hayyan M; Ngoh GC; Wong WF; Looi CY
    J Control Release; 2019 Dec; 316():168-195. PubMed ID: 31669211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of arginine-based therapeutic deep eutectic solvents as drug solubilization vehicles for active pharmaceutical ingredients.
    Gutiérrez A; Aparicio S; Atilhan M
    Phys Chem Chem Phys; 2019 May; 21(20):10621-10634. PubMed ID: 31080981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on drug solubility enhancement using deep eutectic solvents and their derivatives.
    Li Z; Lee PI
    Int J Pharm; 2016 May; 505(1-2):283-8. PubMed ID: 27079143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-embedded deep eutectic solvents (PEDES) as a novel bio-enabling formulation approach.
    Panbachi S; Beranek J; Kuentz M
    Eur J Pharm Sci; 2023 Jul; 186():106463. PubMed ID: 37169098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery.
    Javed S; Mangla B; Sultan MH; Almoshari Y; Sivadasan D; Alqahtani SS; Madkhali OA; Ahsan W
    Heliyon; 2024 May; 10(9):e29783. PubMed ID: 38694051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sketching neoteric solvents for boosting drugs bioavailability.
    Álvarez MS; Zhang Y
    J Control Release; 2019 Oct; 311-312():225-232. PubMed ID: 31521743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep eutectic systems: An overview of fundamental aspects, current understanding and drug delivery applications.
    Chakraborty S; Chormale JH; Bansal AK
    Int J Pharm; 2021 Dec; 610():121203. PubMed ID: 34673164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep eutectic solvents: Recent advances in fabrication approaches and pharmaceutical applications.
    Liu Y; Wu Y; Liu J; Wang W; Yang Q; Yang G
    Int J Pharm; 2022 Jun; 622():121811. PubMed ID: 35550409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubility of pharmaceutical ingredients in triglycerides.
    Brinkmann J; Huxoll F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2019 Dec; 145():113-120. PubMed ID: 31682903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active pharmaceutical ingredients (APIs) in ionic liquids: An effective approach for API physiochemical parameter optimization.
    Handa M; Almalki WH; Shukla R; Afzal O; Altamimi ASA; Beg S; Rahman M
    Drug Discov Today; 2022 Sep; 27(9):2415-2424. PubMed ID: 35697283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supercritical fluid particle design for poorly water-soluble drugs (review).
    Sun Y
    Curr Pharm Des; 2014; 20(3):349-68. PubMed ID: 23651403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.